Tirzepatide, a recently approved medication, is creating considerable interest within the medical community. It functions differently from traditional diabetes therapies , targeting both receptors involved in sugar regulation and appetite . Initial studies have demonstrated impressive efficacy in lowering blood levels in individuals with diabetes o